Free Trial

Ambev (ABEV) Financials

Ambev logo
$2.50 -0.02 (-0.79%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$2.47 -0.03 (-1.20%)
As of 05:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Ambev

Annual Income Statements for Ambev

This table shows Ambev's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
2,335 2,989 2,735 2,273 2,191 2,931 2,833 2,195 3,857 3,138
Consolidated Net Income / (Loss)
2,401 3,083 2,817 2,354 2,259 3,033 2,924 2,351 4,022 3,253
Net Income / (Loss) Continuing Operations
3,218 3,300 2,532 2,468 2,259 3,033 2,924 2,351 4,022 3,253
Total Pre-Tax Income
3,151 3,099 2,693 2,468 2,598 3,220 3,382 3,875 4,119 4,171
Total Operating Income
3,526 3,881 3,346 3,064 3,075 4,000 4,420 4,997 5,258 4,743
Total Gross Profit
7,412 8,336 7,432 6,672 6,028 7,546 7,984 9,019 8,891 7,743
Total Revenue
14,465 16,433 15,079 13,068 11,239 12,940 12,945 14,462 14,018 11,800
Operating Revenue
14,465 16,433 15,079 13,068 11,239 12,940 12,945 14,462 14,018 11,800
Total Cost of Revenue
7,053 8,098 7,647 6,396 5,211 5,394 4,961 5,443 5,127 4,057
Operating Cost of Revenue
7,053 8,098 7,647 6,396 5,211 5,394 4,961 5,443 5,127 4,057
Total Operating Expenses
3,887 4,455 4,086 3,608 2,953 3,546 3,564 3,990 3,633 3,001
Selling, General & Admin Expense
1,003 1,087 991 875 568 667 609 791 666 576
Marketing Expense
1,396 1,528 1,388 1,262 1,227 1,417 1,474 1,695 1,821 1,350
Other Operating Expenses / (Income)
1,488 1,840 1,707 1,471 1,159 1,462 1,455 1,503 1,146 1,075
Total Other Income / (Expense), net
-308 -581 -814 -596 -477 -779 -1,038 -1,122 -1,139 -572
Interest Expense
729 1,056 1,351 974 1,045 1,181 1,207 1,333 1,413 900
Interest & Investment Income
421 514 542 399 577 408 169 212 275 327
Other Income / (Expense), net
0.63 -38 -5.51 -21 -8.34 -5.55 0.26 -0.94 -1.54 0.78
Net Income / (Loss) Attributable to Noncontrolling Interest
-66 -94 -82 -81 -68 -102 -91 -157 -165 -115
Basic Earnings per Share
$0.15 $0.19 $0.17 $0.81 $0.72 $0.75 $0.70 $0.14 $0.80 $0.79
Weighted Average Basic Shares Outstanding
15.76B 15.75B 15.75B 15.74B 15.73B 15.73B 15.72B 15.71B - -
Diluted Earnings per Share
$0.15 $0.19 $0.17 $0.80 $0.72 $0.74 $0.69 $0.14 $0.79 $0.79
Weighted Average Diluted Shares Outstanding
15.76B 15.75B 15.75B 15.74B 15.73B 15.73B 15.72B 15.71B - -
Weighted Average Basic & Diluted Shares Outstanding
15.76B 15.75B 15.75B 15.74B 15.73B 15.73B 15.72B 15.71B - -

Quarterly Income Statements for Ambev

No quarterly income statements for Ambev are available.


Annual Cash Flow Statements for Ambev

This table details how cash moves in and out of Ambev's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
7,684 5,836 4,433 5,466 6,026 6,042 4,694 7,659 5,625 7,567
Net Cash From Operating Activities
8,461 7,106 5,652 7,223 6,675 7,651 4,728 9,393 6,865 9,255
Net Cash From Continuing Operating Activities
8,461 7,106 5,652 7,223 6,675 7,651 4,702 9,393 6,865 9,255
Net Income / (Loss) Continuing Operations
2,401 3,083 2,817 2,354 2,259 3,033 2,924 2,351 4,022 3,253
Consolidated Net Income / (Loss)
2,401 3,083 2,817 2,354 2,259 3,033 2,924 2,351 4,022 3,253
Depreciation Expense
1,152 1,323 1,127 968 995 1,163 1,146 1,219 1,080 777
Non-Cash Adjustments To Reconcile Net Income
3,909 3,013 1,756 2,621 2,658 3,103 1,039 4,411 2,019 3,120
Changes in Operating Assets and Liabilities, net
999 -314 -48 1,280 763 352 -407 1,412 -255 2,106
Net Cash From Investing Activities
-758 -1,233 -1,228 -1,373 -981 -1,259 -947 -968 -1,823 -1,515
Net Cash From Continuing Investing Activities
-758 -1,233 -1,228 -1,373 -981 -1,259 -34 -968 -1,823 -1,515
Purchase of Property, Plant & Equipment
-768 -1,237 -1,236 -1,377 -903 -1,261 - -967 -1,270 -1,329
Acquisitions
1.67 -9.58 -0.57 -24 -83 -24 -34 -101 -561 -306
Sale of Property, Plant & Equipment
7.97 14 8.53 29 5.62 29 - 16 19 18
Net Cash From Financing Activities
-19 -37 8.46 -384 332 -350 -3,519 -766 583 -174
Net Cash From Continuing Financing Activities
-19 -37 8.46 -384 332 -350 0.00 -766 583 -174
Repayment of Debt
-98 -47 -44 -440 -393 -585 - -1,643 -583 -1,428
Issuance of Debt
79 10 52 57 725 235 - 877 1,166 1,254
Cash Interest Paid
120 137 156 89 148 101 - 218 223 65
Cash Interest Received
264 257 207 68 62 135 - 102 184 166
Cash Income Taxes Paid
585 335 174 234 316 506 - 651 1,642 537

Quarterly Cash Flow Statements for Ambev

No quarterly cash flow statements for Ambev are available.


Annual Balance Sheets for Ambev

This table presents Ambev's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 1/1/2018 12/31/2016
Total Assets
26,279 27,338 26,099 24,862 24,103 25,315 24,666 26,693 25,772
Total Current Assets
7,729 6,533 6,408 6,307 6,290 6,067 5,645 6,693 6,662
Cash & Equivalents
4,624 3,310 2,824 2,983 3,290 2,961 2,954 3,126 2,421
Short-Term Investments
201 57 127 378 368 44 41 40 119
Accounts Receivable
1,014 1,183 1,012 859 828 1,119 1,257 1,330 1,343
Inventories, net
1,890 1,982 2,445 1,973 1,464 1,488 1,392 1,304 1,336
Plant, Property, & Equipment, net
4,879 5,488 5,686 5,242 4,768 5,617 5,718 6,251 5,888
Plant, Property & Equipment, gross
4,879 5,488 5,686 5,242 4,768 5,617 5,718 6,251 5,888
Total Noncurrent Assets
13,641 15,267 14,005 13,313 13,044 13,631 13,113 13,749 13,222
Long-Term Investments
64 60 63 55 65 75 66 72 92
Goodwill
7,171 7,832 7,680 7,608 7,705 8,711 8,833 9,481 9,379
Intangible Assets
2,026 2,070 1,745 1,559 1,459 1,569 1,505 1,411 1,613
Noncurrent Deferred & Refundable Income Taxes
3,683 4,685 3,899 3,416 3,134 2,537 2,074 1,645 1,028
Employee Benefit Assets
11 12 11 5.00 6.47 14 - 18 10
Other Noncurrent Operating Assets
685 609 609 672 674 724 635 1,122 1,100
Total Liabilities & Shareholders' Equity
26,279 27,338 26,099 24,862 24,103 25,315 24,666 26,693 25,772
Total Liabilities
10,176 10,820 10,335 9,791 9,635 9,750 9,860 12,333 11,432
Total Current Liabilities
6,545 6,473 6,303 7,408 7,111 7,232 6,496 8,591 7,600
Short-Term Debt
558 722 713 556 923 762 1,057 1,368 1,659
Accounts Payable
4,132 4,844 4,699 4,609 3,849 3,827 3,653 3,632 3,414
Dividends Payable
1,372 315 277 256 473 238 208 537 527
Current Employee Benefit Liabilities
450 439 442 438 178 207 - 316 211
Other Current Nonoperating Liabilities
33 155 172 31 88 116 - 116 263
Total Noncurrent Liabilities
1,905 2,171 2,291 2,383 2,524 2,519 2,250 3,742 3,832
Noncurrent Deferred & Payable Income Tax Liabilities
810 684 705 577 586 590 625 703 716
Noncurrent Employee Benefit Liabilities
362 415 409 573 682 673 587 698 657
Other Noncurrent Operating Liabilities
732 1,070 1,163 1,140 1,256 1,256 1,038 2,340 2,451
Other Noncurrent Nonoperating Liabilities
1.08 2.41 0.00 88 0.00 0.02 - 0.72 8.30
Total Equity & Noncontrolling Interests
16,103 16,517 15,764 15,071 14,468 15,565 15,183 14,361 14,340
Total Preferred & Common Equity
15,951 16,275 15,504 14,824 14,211 15,247 14,872 13,765 13,779
Total Common Equity
15,951 16,275 15,504 14,824 14,211 15,247 14,495 13,765 13,779
Common Stock
9,416 11,990 10,997 10,411 11,147 14,398 14,872 17,395 17,710
Other Equity Adjustments
6,536 4,285 4,507 4,413 3,064 849 - -3,523 -3,931
Noncontrolling Interest
152 242 260 247 257 318 311 596 561

Quarterly Balance Sheets for Ambev

No quarterly balance sheets for Ambev are available.


Annual Metrics And Ratios for Ambev

This table displays calculated financial ratios and metrics derived from Ambev's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
-11.98% 8.98% 15.39% 16.27% -13.14% -0.04% -10.49% 3.17% 18.79% 0.00%
EBITDA Growth
-9.43% 15.63% 11.38% -1.24% -21.25% -7.35% -10.44% -1.90% 14.78% 0.00%
EBIT Growth
-8.24% 15.03% 9.78% -0.77% -23.22% -9.64% -11.54% -4.95% 10.81% 0.00%
NOPAT Growth
-9.16% 15.98% 9.22% 14.60% -29.02% -1.46% 26.06% -40.95% 38.80% 0.00%
Net Income Growth
-22.13% 9.45% 19.68% 4.22% -25.52% 3.70% 24.38% -41.54% 23.63% 0.00%
EPS Growth
-21.78% 9.33% -78.40% 11.43% -3.39% 7.05% 400.29% -82.52% 0.37% 0.00%
Operating Cash Flow Growth
19.07% 25.71% -21.74% 8.21% -12.76% 61.83% -49.67% 36.82% -25.82% 0.00%
Free Cash Flow Firm Growth
61.25% 1,059.20% -89.97% -33.29% 13.87% -0.74% -11.66% 144.88% 0.00% 0.00%
Invested Capital Growth
-9.35% 4.74% 24.42% 2.98% -10.09% 1.59% 1.84% -7.20% 0.00% 0.00%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - -
Gross Margin
51.24% 50.72% 49.29% 51.05% 53.64% 58.32% 61.68% 62.36% 63.43% 65.62%
EBITDA Margin
32.34% 31.43% 29.63% 30.69% 36.14% 39.86% 43.00% 42.98% 45.20% 46.78%
Operating Margin
24.37% 23.62% 22.19% 23.44% 27.36% 30.91% 34.14% 34.56% 37.51% 40.19%
EBIT Margin
24.38% 23.38% 22.15% 23.29% 27.29% 30.87% 34.15% 34.55% 37.50% 40.20%
Profit (Net Income) Margin
16.60% 18.76% 18.68% 18.01% 20.10% 23.44% 22.59% 16.26% 28.69% 27.57%
Tax Burden Percent
76.19% 99.50% 104.61% 95.37% 86.94% 94.17% 86.48% 60.67% 97.65% 77.99%
Interest Burden Percent
89.37% 80.64% 80.62% 81.11% 84.72% 80.63% 76.50% 77.56% 78.35% 87.92%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 13.06% 5.83% 13.52% 39.33% 2.35% 22.01%
Return on Invested Capital (ROIC)
22.54% 24.20% 23.68% 24.69% 20.70% 27.91% 28.81% 22.21% 72.50% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
190.94% 805.77% 64.77% 54.77% 40.42% 66.93% 88.42% 120.03% 1,339.73% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-7.82% -5.10% -5.41% -8.75% -5.66% -8.19% -9.02% -5.82% -16.41% 0.00%
Return on Equity (ROE)
14.72% 19.10% 18.27% 15.94% 15.04% 19.73% 19.80% 16.38% 56.09% 0.00%
Cash Return on Invested Capital (CROIC)
32.35% 19.57% 1.92% 21.75% 31.33% 26.33% 26.99% 29.68% -127.50% 0.00%
Operating Return on Assets (OROA)
13.15% 14.38% 13.11% 12.43% 12.41% 15.98% 17.21% 19.05% 20.40% 0.00%
Return on Assets (ROA)
8.96% 11.54% 11.06% 9.61% 9.14% 12.14% 11.39% 8.96% 15.60% 0.00%
Return on Common Equity (ROCE)
14.54% 18.81% 17.97% 15.67% 14.75% 19.08% 18.94% 15.72% 53.89% 0.00%
Return on Equity Simple (ROE_SIMPLE)
15.05% 18.94% 18.17% 15.88% 15.89% 19.89% 19.66% 17.08% 29.19% 0.00%
Net Operating Profit after Tax (NOPAT)
3,526 3,881 3,346 3,064 2,673 3,767 3,822 3,032 5,134 3,699
NOPAT Margin
24.37% 23.62% 22.19% 23.44% 23.79% 29.11% 29.53% 20.97% 36.63% 31.35%
Net Nonoperating Expense Percent (NNEP)
-168.41% -781.57% -41.08% -30.08% -19.72% -39.02% -59.61% -97.82% -1,267.23% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
21.16% 22.51% 20.29% - - - - - - -
Cost of Revenue to Revenue
48.76% 49.28% 50.71% 48.95% 46.36% 41.68% 38.32% 37.64% 36.57% 34.38%
SG&A Expenses to Revenue
6.93% 6.61% 6.57% 6.69% 5.05% 5.15% 4.71% 5.47% 4.75% 4.88%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
26.87% 27.11% 27.10% 27.61% 26.28% 27.41% 27.53% 27.59% 25.92% 25.43%
Earnings before Interest and Taxes (EBIT)
3,526 3,843 3,341 3,043 3,067 3,994 4,420 4,997 5,256 4,744
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4,679 5,166 4,467 4,011 4,061 5,157 5,567 6,215 6,336 5,520
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.83 2.56 2.48 2.68 2.92 4.04 3.48 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
4.32 6.55 6.32 7.02 8.23 12.42 12.15 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.01 2.54 2.55 3.04 3.70 4.77 3.90 0.00 0.00 0.00
Price to Earnings (P/E)
12.48 13.96 14.04 17.47 18.96 21.04 17.82 0.00 0.00 0.00
Dividend Yield
0.00% 5.70% 5.91% 1.51% 2.99% 3.08% 4.54% 3.23% 4.95% 6.63%
Earnings Yield
8.01% 7.16% 7.12% 5.72% 5.27% 4.75% 5.61% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.68 2.39 2.32 2.95 3.19 4.39 3.65 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
1.73 2.39 2.41 2.84 3.47 4.61 3.77 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
5.34 7.60 8.14 9.25 9.60 11.57 8.77 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
7.08 10.21 10.89 12.19 12.72 14.94 11.04 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
7.08 10.11 10.87 12.11 14.59 15.84 12.77 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
2.95 5.52 6.44 5.14 5.84 7.80 10.32 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
4.93 12.51 134.34 13.74 9.64 16.79 13.64 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.03 0.04 0.05 0.04 0.06 0.05 0.07 0.10 0.12 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.04 -0.01 -0.08 -0.16 -0.14 -0.12 -0.10 -0.05 -0.01 0.00
Leverage Ratio
1.64 1.66 1.65 1.66 1.65 1.63 1.74 1.83 1.80 0.00
Compound Leverage Factor
1.47 1.33 1.33 1.34 1.39 1.31 1.33 1.42 1.41 0.00
Debt to Total Capital
3.35% 4.19% 4.41% 3.59% 5.99% 4.67% 6.51% 8.70% 10.37% 0.00%
Short-Term Debt to Total Capital
3.35% 4.19% 4.33% 3.56% 5.99% 4.67% 6.51% 8.70% 10.37% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.09% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.91% 1.40% 1.57% 1.58% 1.67% 1.95% 1.91% 3.79% 3.51% 0.00%
Common Equity to Total Capital
95.74% 94.41% 94.02% 94.83% 92.33% 93.38% 89.25% 87.51% 86.12% 0.00%
Debt to EBITDA
0.12 0.14 0.16 0.14 0.23 0.15 0.19 0.22 0.26 0.00
Net Debt to EBITDA
-0.93 -0.52 -0.51 -0.71 -0.69 -0.45 -0.36 -0.30 -0.15 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.16 0.19 0.22 0.18 0.35 0.20 0.28 0.45 0.32 0.00
Net Debt to NOPAT
-1.23 -0.70 -0.68 -0.93 -1.05 -0.62 -0.52 -0.62 -0.19 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.77 3.38 3.23 3.31 3.43 4.77 4.15 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
1.21% 1.55% 1.64% 1.71% 1.91% 3.27% 4.35% 4.03% 3.91% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.18 1.01 1.02 0.85 0.88 0.84 0.87 0.78 0.88 0.00
Quick Ratio
0.89 0.70 0.63 0.57 0.63 0.57 0.65 0.52 0.51 0.00
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
5,061 3,138 271 2,699 4,046 3,553 3,580 4,052 -9,030 0.00
Operating Cash Flow to CapEx
1,113.28% 580.78% 460.51% 535.57% 743.46% 620.90% 0.00% 987.34% 548.75% 706.15%
Free Cash Flow to Firm to Interest Expense
6.94 2.97 0.20 2.77 3.87 3.01 2.97 3.04 -6.39 0.00
Operating Cash Flow to Interest Expense
11.60 6.73 4.18 7.42 6.38 6.48 3.92 7.05 4.86 10.29
Operating Cash Flow Less CapEx to Interest Expense
10.56 5.57 3.28 6.03 5.53 5.43 3.92 6.33 3.97 8.83
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.54 0.62 0.59 0.53 0.45 0.52 0.50 0.55 0.54 0.00
Accounts Receivable Turnover
13.17 14.97 16.12 15.48 11.55 10.89 10.00 10.82 10.44 0.00
Inventory Turnover
3.64 3.66 3.46 3.72 3.53 3.75 3.68 4.12 3.84 0.00
Fixed Asset Turnover
2.79 2.94 2.76 2.61 2.16 2.28 2.16 2.38 2.38 0.00
Accounts Payable Turnover
1.57 1.70 1.64 1.51 1.36 1.44 1.36 1.55 1.50 0.00
Days Sales Outstanding (DSO)
27.72 24.38 22.65 23.57 31.62 33.51 36.48 33.73 34.96 0.00
Days Inventory Outstanding (DIO)
100.21 99.78 105.44 98.08 103.39 97.43 99.19 88.52 95.14 0.00
Days Payable Outstanding (DPO)
232.25 215.06 222.14 241.33 268.84 253.08 268.01 236.24 243.07 0.00
Cash Conversion Cycle (CCC)
-104.32 -90.91 -94.05 -119.68 -133.84 -122.13 -132.34 -113.98 -112.97 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
14,875 16,410 15,667 12,592 12,227 13,600 13,387 13,144 14,165 0.00
Invested Capital Turnover
0.92 1.02 1.07 1.05 0.87 0.96 0.98 1.06 1.98 0.00
Increase / (Decrease) in Invested Capital
-1,535 743 3,075 365 -1,373 213 242 -1,020 14,165 0.00
Enterprise Value (EV)
24,966 39,252 36,372 37,098 39,003 59,669 48,812 0.00 0.00 0.00
Market Capitalization
29,145 41,714 38,399 39,705 41,547 61,670 50,505 0.00 0.00 0.00
Book Value per Share
$1.01 $1.03 $0.99 $0.94 $0.90 $0.97 $0.92 $0.88 $0.00 $0.00
Tangible Book Value per Share
$0.43 $0.40 $0.39 $0.36 $0.32 $0.32 $0.26 $0.18 $0.00 $0.00
Total Capital
16,661 17,239 16,491 15,632 15,391 16,327 16,241 15,729 15,999 0.00
Total Debt
558 722 727 562 923 762 1,057 1,368 1,659 0.00
Total Long-Term Debt
0.00 0.00 14 5.47 0.00 0.00 0.00 0.54 0.00 0.00
Net Debt
-4,331 -2,705 -2,287 -2,854 -2,801 -2,319 -2,004 -1,870 -974 0.00
Capital Expenditures (CapEx)
760 1,223 1,227 1,349 898 1,232 0.00 951 1,251 1,311
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3,083 -2,586 -2,133 -3,906 -3,557 -3,408 -2,790 -3,697 -1,819 0.00
Debt-free Net Working Capital (DFNWC)
1,742 781 818 -545 102 -402 206 -530 721 0.00
Net Working Capital (NWC)
1,184 59 105 -1,102 -821 -1,164 -851 -1,898 -938 0.00
Net Nonoperating Expense (NNE)
1,125 798 529 710 415 734 898 681 1,113 446
Net Nonoperating Obligations (NNO)
-1,228 -107 -97 -2,479 -2,241 -1,965 -1,796 -1,216 -176 0.00
Total Depreciation and Amortization (D&A)
1,152 1,323 1,127 968 995 1,163 1,146 1,219 1,080 777
Debt-free, Cash-free Net Working Capital to Revenue
-21.31% -15.74% -14.15% -29.89% -31.65% -26.34% -21.55% -25.56% -12.98% 0.00%
Debt-free Net Working Capital to Revenue
12.04% 4.75% 5.42% -4.17% 0.91% -3.11% 1.59% -3.66% 5.15% 0.00%
Net Working Capital to Revenue
8.18% 0.36% 0.69% -8.43% -7.30% -9.00% -6.58% -13.12% -6.69% 0.00%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.15 $0.92 $0.92 $0.81 $0.72 $0.19 $0.70 $0.47 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
15.76B 15.75B 15.75B 15.74B 15.73B 15.73B 15.72B 15.71B 0.00 0.00
Adjusted Diluted Earnings per Share
$0.15 $0.92 $0.91 $0.80 $0.72 $0.18 $0.70 $0.46 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
15.76B 15.75B 15.75B 15.74B 15.73B 15.73B 15.72B 15.71B 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
15.76B 15.75B 15.75B 15.74B 15.73B 15.73B 15.72B 15.71B 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
2,468 2,717 2,342 2,145 2,673 3,767 3,844 3,033 5,134 3,699
Normalized NOPAT Margin
17.06% 16.53% 15.53% 16.41% 23.79% 29.11% 29.70% 20.97% 36.63% 31.35%
Pre Tax Income Margin
21.79% 18.86% 17.86% 18.89% 23.12% 24.89% 26.12% 26.80% 29.38% 35.35%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
4.83 3.64 2.47 3.13 2.93 3.38 3.66 3.75 3.72 5.27
NOPAT to Interest Expense
4.83 3.67 2.48 3.15 2.56 3.19 3.17 2.27 3.63 4.11
EBIT Less CapEx to Interest Expense
3.79 2.48 1.56 1.74 2.07 2.34 3.66 3.04 2.83 3.82
NOPAT Less CapEx to Interest Expense
3.79 2.52 1.57 1.76 1.70 2.15 3.17 1.56 2.75 2.65
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Ambev

No quarterly metrics and ratios for Ambev are available.


Frequently Asked Questions About Ambev's Financials

When does Ambev's financial year end?

According to the most recent income statement we have on file, Ambev's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Ambev's net income changed over the last 9 years?

Ambev's net income appears to be on a downward trend, with a most recent value of $2.40 billion in 2024, falling from $3.25 billion in 2015. The previous period was $3.08 billion in 2023. Check out Ambev's forecast to explore projected trends and price targets.

What is Ambev's operating income?
Ambev's total operating income in 2024 was $3.53 billion, based on the following breakdown:
  • Total Gross Profit: $7.41 billion
  • Total Operating Expenses: $3.89 billion
How has Ambev revenue changed over the last 9 years?

Over the last 9 years, Ambev's total revenue changed from $11.80 billion in 2015 to $14.47 billion in 2024, a change of 22.6%.

How much debt does Ambev have?

Ambev's total liabilities were at $10.18 billion at the end of 2024, a 6.0% decrease from 2023, and a 11.0% decrease since 2016.

How much cash does Ambev have?

In the past 8 years, Ambev's cash and equivalents has ranged from $2.42 billion in 2016 to $4.62 billion in 2024, and is currently $4.62 billion as of their latest financial filing in 2024.

How has Ambev's book value per share changed over the last 9 years?

Over the last 9 years, Ambev's book value per share changed from 0.00 in 2015 to 1.01 in 2024, a change of 101.3%.



This page (NYSE:ABEV) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners